Skip to content

Age-specific burden of cervical cancer and attributable risk factors in Asia, 1990-2023: A global burden of disease study 2023.

Aug 2026 · European Journal of Obstetrics, Gynecology, and Reproductive Biology · Vol 326, pp. 115363 · 0 citations · 26 references
Medicine

TL;DR

Cervical cancer burden attributable to unsafe sex showed the highest DALY rate among females aged 50-69 years and the highest mortality rate among those aged 70 years or older, and overall, cervical cancer burden exhibited an inverse association with SDI.

Abstract

Background

Despite global elimination initiatives, cervical cancer remains a major public health burden across Asia. We aimed to assess regional and age-specific trends in cervical cancer burden using data from the Global Burden of Disease Study (GBD) 2023.

Methods

We analyzed GBD 2023 to estimate the burden of cervical cancer across 34 Asian countries from 1990 to 2023. Age-standardized incidence rate (ASIR), mortality rate (ASMR), and DALY rate (ASDR) were assessed by region and Socio-demographic Index (SDI), while age-specific rates were evaluated for females aged 15-49, 50-69, and ≥70 years. Cervical cancer was defined as malignant neoplasm of the cervix, and burden attributable to unsafe sex and tobacco use was estimated using population-attributable fractions derived from exposure data and relative risks. Estimates are presented as means with 95% uncertainty intervals (UIs).

Results

In 2023, South Asia exhibited the highest cervical cancer burden, with an ASIR of 22.07 (95% UI, 14.68-33.20) per 100,000 population, whereas High-income Asia Pacific had the lowest ASIR at 11.89 (9.94-14.37). A similar pattern was observed for ASDR: South Asia had the highest rate at 377.19 (95% UI, 255.79-558.38) per 100,000 population, while High-income Asia Pacific exhibited the lowest rate at 96.04 (84.08-109.75). From 1990 to 2023, ASIR and ASDR generally declined across Asia, although substantial regional disparities persisted. Across all five regions, the relative contribution of females aged 15-49 years to cervical cancer burden increased, while that of older age groups generally decreased; however, the absolute incidence rates among females aged 15-49 years increased only in Southeast Asia and High-income Asia Pacific. Cervical cancer burden attributable to unsafe sex showed the highest DALY rate among females aged 50-69 years and the highest mortality rate among those aged 70 years or older. Overall, cervical cancer burden exhibited an inverse association with SDI.

Conclusion

Cervical cancer remains a substantial burden in low-SDI Asian countries, with an increasing relative contribution among females aged 15-49 years. Age-specific and context-specific prevention strategies are urgently needed to reduce inequalities and accelerate elimination efforts in Asia.

View source

Similar papers

Sep 2026

[Analysis of the global disease burden of cervical cancer in women aged 65 years and older based on the global burden of disease database].

Analysis of the disease burden and attributable risk factors of cervical cancer among women aged 65 years and older globally from 1990 to 2021 explored its association with the Socio-demographic Index (SDI) as well as age-specific distribution characteristics.

X.-H. Yuan, Y. Chen, Z. Kuang et al. · 0 citations
Open access Jul 2026

Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021.

Differentiated, evidence-based strategies tailored to national burden characteristics, addressing demographic shifts, key health system gaps, and human papillomavirus genotype disparities, are critically needed to successfully achieve the World Health Organization 2030 global cervical cancer elimination targets.

Xiang-Wen Li, Siyu Pan, Peng-Fei Qu et al. · 0 citations
Open access Jun 2026

Global, regional, and national burden of colorectal cancer attributable to modifiable risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Substantial disparities in CRC burden attributable to modifiable risk factors exist across sociodemographic contexts, and targeted, equity-oriented public health strategies are essential to mitigate the projected burden increase, particularly within BRICS countries, by 2050.

Miao Yu, Yi-Ping Lu · 0 citations
Open access Sep 2026

The burden of bladder cancer and kidney cancer attributable to smoking in Latin America and the Caribbean from 1990 to 2023 and projections to 2050

Age-standardized rates declined overall, whereas the absolute numbers of deaths and DALYs are projected to increase in Latin America and the Caribbean, and the burden of both cancers was positively associated with SDI in 2023.

Jia Deng, Bing Yang, Zhen-Zhen Wu et al. · 0 citations
Open access Aug 2026

Long-term trends and future projections of cervical cancer burden in China, 1990-2023: a Global Burden of Disease 2023 analysis.

Decomposition showed that population aging and growth offset favorable epidemiological changes, and projections suggested continued declines in ASDR with relatively stable deaths through 2045, underscore the urgent need to strengthen human papillomavirus vaccination coverage and expand equitable cervical cancer screeni...

Chao Ma, P. Yin, Nan Hong · 0 citations
Open access Jul 2026

Global burden of skin cancers and trends from 1990 to 2021: An observational study based on secondary analysis of GBD 2021

The study indicates that skin cancer remains an important public health issue worldwide and countries and regions should attach great importance to the prevention and treatment of skin cancers, and develop and improve preventive measures.

Ruosu Zhang, Yike Zhao, Yanling Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.